Amber van Broekhoven

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome

Tjerk S.J. Opstal, Aernoud T.L. Fiolet, Amber van Broekhoven et al. · Journal of the American College of Cardiology · 2021 · 52 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Atherosclerosis +6

Immunosuppressive Drug Azathioprine Reduces Aneurysm Progression Through Inhibition of Rac1 and c-Jun-Terminal-N-Kinase in Endothelial Cells

Goran Marinković, Stijntje Hibender, Mark Hoogenboezem et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 37 citations · Full text

The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial

Amber van Broekhoven, Niekbachsh Mohammadnia, Max J. M. Silvis et al. · Clinical Drug Investigation · 2022 · 18 citations · Full text

The effects of colchicine on lipoprotein(a)- and oxidized phospholipid-associated cardiovascular disease risk

Niekbachsh Mohammadnia, Amber van Broekhoven, Willem A. Bax et al. · European Journal of Preventive Cardiology · 2024 · 17 citations · Full text

Short‐term LPS induces aortic valve thickening in ApoE*3Leiden mice

Amber van Broekhoven, Paul A.J. Krijnen, Wessel W. Fuijkschot et al. · European Journal of Clinical Investigation · 2019 · 12 citations · Full text